VIRAX BIOLABS GROUP LTD (VRAX) Stock Balance Sheet
NASDAQ:VRAX - KYG9495L1251 - Common Stock
0.565 USD
-0.04 (-6.87%)
0.5622 USD
0 (-0.5%)
| 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 4.23M | 3.59M | 9.35M | 20.00K | 20.00K | |||
| Receivables | 30.70K | 217.80K | N/A | 0.00 | 0.00 | |||
| Inventories | 94.70K | 60.40K | 0.00 | 20.00K | 20.00K | |||
| Other Current Assets | 539.40K | 512.80K | 281.50K | 10.00K | N/A | |||
| Total Current Assets | 4.89M | 4.38M | 9.63M | 50.00K | 40.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.53M | 1.10M | N/A | N/A | N/A | |||
| Intangibles | N/A | 0.00 | 178.40K | N/A | N/A | |||
| Total Non-Current Assets | 1.53M | 1.10M | 178.40K | 0.00 | 0.00 | |||
| TOTAL ASSETS | 6.43M | 5.48M | 9.81M | 50.00K | 40.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 32.50K | 0.00 | 146.30K | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 53.00K | 48.00K | N/A | N/A | N/A | |||
| Accrued Expenses | 194.10K | 0.00 | 409.70K | N/A | 280.00K | |||
| Accounts Payable | 393.70K | 120.90K | 314.20K | 1.12M | 220.00K | |||
| Other Current Liabilities | N/A | 0.00 | 38.30K | 130.00K | 370.00K | |||
| Total Current Liabilities | 673.20K | 168.90K | 908.40K | 1.25M | 870.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 291.50K | 176.40K | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 57.60K | -51.70K | -222.40K | -230.00K | -180.00K | |||
| TOTAL LIABILITIES | 730.80K | 117.20K | 686.00K | 1.02M | 690.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 5.58M | 5.36M | 9.13M | -970.00K | -590.00K | |||
| Minority Interest | -234.00K | -228.00K | -222.40K | -220.00K | -180.00K | |||
| Common Shares | 4.30K | 2.60K | 1.60K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 112.30K | 2.00K | -1.70K | 0.00 | -60.00K | |||
| Shares Outstanding | 4.34M | 2.57M | 1.55M | 11.37M | 11.37M | |||
| Tangible Book Value per Share | 1.31 | 2.09 | 5.76 | -0.09 | -0.06 | |||
| Total Shareholders' Equity | 5.70M | 5.37M | 9.13M | -970.00K | -650.00K | |||
| TOTAL LIABILITIES AND EQUITY | 6.43M | 5.48M | 9.81M | 50.00K | 40.00K | |||
| Statistics | ||||||||
| Debt/Equity | 0.06 | 0.03 | N/A | N/A | N/A | |||
| Current Ratio | 7.27 | 25.93 | 10.61 | 0.04 | 0.05 | |||
| Return On Assets (ROA) | -94.31% | -122.78% | -55.62% | -3420.00% | -1625.00% | |||
| Return On Equity (ROE) | -106.41% | -125.47% | -59.80% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21